Unihealth Hospitals Ltd
Incorporated in 2010, Unihealth Consultancy Ltd is in the business of Medical Tour Operator and Health Consultancy Service & Trader in Medical Equipments[1]
- Market Cap ₹ 728 Cr.
- Current Price ₹ 458
- High / Low ₹ 530 / 134
- Stock P/E 112
- Book Value ₹ 50.5
- Dividend Yield 0.00 %
- ROCE 12.0 %
- ROE 8.88 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 50.0% CAGR over last 5 years
Cons
- Stock is trading at 9.06 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 6.69% over last 3 years.
- Earnings include an other income of Rs.6.69 Cr.
- Company has high debtors of 254 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 0.63 | 1.61 | 1.92 | 4.23 | 3.56 | 6.54 | |
| 0.94 | 0.79 | 1.36 | 2.26 | 3.35 | 4.06 | |
| Operating Profit | -0.31 | 0.82 | 0.56 | 1.97 | 0.21 | 2.48 |
| OPM % | -49.21% | 50.93% | 29.17% | 46.57% | 5.90% | 37.92% |
| 0.06 | 0.94 | 1.79 | 2.33 | 3.31 | 6.69 | |
| Interest | 0.80 | 1.19 | 1.15 | 0.36 | 0.03 | 0.10 |
| Depreciation | 0.11 | 0.09 | 0.08 | 0.16 | 0.28 | 0.24 |
| Profit before tax | -1.16 | 0.48 | 1.12 | 3.78 | 3.21 | 8.83 |
| Tax % | 0.00% | 0.00% | -19.64% | 19.84% | 27.41% | 26.50% |
| -1.16 | 0.48 | 1.34 | 3.04 | 2.33 | 6.49 | |
| EPS in Rs | 4.13 | |||||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 60% |
| 3 Years: | 50% |
| TTM: | 84% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 50% |
| 3 Years: | 69% |
| TTM: | 179% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 165% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 7% |
| 3 Years: | 7% |
| Last Year: | 9% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 1.34 | 1.34 | 1.39 | 15.40 | 15.40 | 15.70 |
| Reserves | 4.69 | 5.17 | 11.28 | 49.07 | 51.41 | 63.62 |
| 6.96 | 11.60 | 12.08 | 3.30 | 2.66 | 0.00 | |
| 3.67 | 0.42 | 0.61 | 0.71 | 0.95 | 2.45 | |
| Total Liabilities | 16.66 | 18.53 | 25.36 | 68.48 | 70.42 | 81.77 |
| 1.60 | 1.50 | 1.42 | 3.09 | 3.15 | 2.90 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 6.15 | 6.15 | 6.34 | 18.37 | 30.50 | 30.49 |
| 8.91 | 10.88 | 17.60 | 47.02 | 36.77 | 48.38 | |
| Total Assets | 16.66 | 18.53 | 25.36 | 68.48 | 70.42 | 81.77 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| -0.32 | 2.25 | 1.97 | -2.44 | 0.57 | 4.03 | |
| 0.06 | -6.13 | -7.17 | -10.50 | -21.93 | -5.41 | |
| 0.19 | 3.93 | 5.09 | 39.55 | -1.13 | 4.32 | |
| Net Cash Flow | -0.07 | 0.05 | -0.11 | 26.61 | -22.48 | 2.94 |
| Free Cash Flow | -0.29 | 2.25 | 1.97 | -4.26 | 0.23 | 4.04 |
| CFO/OP | 103% | 274% | 352% | -96% | 700% | 256% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 857.46 | 476.09 | 117.86 | 225.21 | 298.36 | 254.50 |
| Inventory Days | 0.00 | 0.00 | ||||
| Days Payable | ||||||
| Cash Conversion Cycle | 857.46 | 476.09 | 117.86 | 225.21 | 298.36 | 254.50 |
| Working Capital Days | 4,745.00 | 562.24 | 26.61 | 361.55 | 411.14 | 343.79 |
| ROCE % | 10.74% | 10.59% | 8.95% | 4.72% | 12.00% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Annual Clinical Procedures Count |
|
||
| Annual Patients Treated Count |
|||
| Bed Capacity - UMC Victoria Hospital (Uganda) Beds |
|||
| Bed Capacity - UMC Zhahir Hospital (Nigeria) Beds |
|||
| Hospital Occupancy - Uganda % |
|||
| Total Operational Bed Capacity Beds |
|||
| Beds Under Consultancy Projects Beds |
|||
| Number of Doctors & Specialists Count |
|||
| Total Employee Workforce Count |
|||
Extracted by Screener AI
Documents
Announcements
-
Analysts/Institutional Investor Meet/Con. Call Updates
3 June 2026 - Audio recording of FY26 audited results earnings call posted online.
-
Investor Presentation
3 June 2026 - Submitted H2 FY26 investor presentation after earnings call; FY26 revenue ₹137.01 Cr, PAT ₹25.83 Cr.
-
Press Release
2 June 2026 - UMC Hospitals, Navi Mumbai performed its first robotic total knee replacement surgery on June 2, 2026.
-
Press Release
1 June 2026 - FY26 consolidated income rose 35% to ₹137.01 crore; profit jumped 83%, with new Navi Mumbai and Uganda hospitals.
-
Updates
30 May 2026 - Unihealth appointed M/s. Joshi & Shah as internal auditor for FY2026-27 on May 29, 2026.
Annual reports
Concalls
-
Nov 2025Transcript PPT
-
May 2025Transcript PPT
-
Nov 2024Transcript PPT REC
-
May 2024Transcript PPT
-
Nov 2023Transcript PPT
Business Overview:[1]
Headquartered in Mumbai, Unihealth Hospitals Ltd is a diversified healthcare service provider with a global presence, particularly in Africa. The company operates under the 'UMC Hospitals' brand and provides:
- Hospital and medical centre services,
- Healthcare consultancy and project management,
- Export and distribution of pharmaceutical and medical consumables,
- Medical value travel facilitation for international patients.